Kovack Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-200
Closed -$3.6K 615
2023
Q1
$3.6K Buy
200
+198
+9,900% +$32K ﹤0.01% 591
2022
Q4
$1.61K Hold
2
﹤0.01% 549
2022
Q3
$3K Buy
2
+1
+100% +$169 ﹤0.01% 553
2022
Q2
$2K Buy
+1
New +$178 ﹤0.01% 606
2020
Q4
Sell
-1
Closed -$1K 641
2020
Q3
$1K Hold
1
﹤0.01% 516
2020
Q2
$1K Hold
1
﹤0.01% 494
2020
Q1
$2K Buy
+1
New +$142 ﹤0.01% 463
2019
Q4
Sell
-3
Closed -$2K 521
2019
Q3
$2K Hold
3
﹤0.01% 497
2019
Q2
$1K Buy
+3
New +$415 ﹤0.01% 471
2018
Q3
Sell
-2
Closed -$1K 494
2018
Q2
$1K Hold
2
﹤0.01% 422
2018
Q1
$112K Buy
+2
New +$270 0.03% 461

Other funds holding JNJ

Kovack Advisors's JNJ Position: Q2 2026 in Review

Kovack Advisors reduced its Johnson & Johnson (JNJ) stake by 8.7% in Q2 2026, selling an estimated $446K and leaving 20,128 shares worth $5.11M. The position accounts for 0.25% of the portfolio, ranked #82.

Kovack Advisors first reported a position in JNJ in Q3 2013 and has held it in 51 quarters since. The position peaked at $7.48M in Q4 2025. 2,122 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Kovack Advisors held 20,128 shares of Johnson & Johnson worth $5.11M as of Q2 2026.
  • Kovack Advisors sold 1,912 Johnson & Johnson shares in Q2 2026, an estimated $446K.
  • Johnson & Johnson made up 0.25% of Kovack Advisors's portfolio in Q2 2026, its #82 holding.
  • Kovack Advisors first reported a position in Johnson & Johnson in Q3 2013 and has held it in 51 quarters since.
  • Kovack Advisors's Johnson & Johnson position peaked at $7.48M in Q4 2025.
  • 2,122 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Kovack Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.